0001209191-16-138301.txt : 20160823
0001209191-16-138301.hdr.sgml : 20160823
20160823161029
ACCESSION NUMBER: 0001209191-16-138301
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160822
FILED AS OF DATE: 20160823
DATE AS OF CHANGE: 20160823
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerulean Pharma Inc.
CENTRAL INDEX KEY: 0001401914
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 204139823
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-996-4300
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Senderowicz Adrian
CENTRAL INDEX KEY: 0001616230
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36395
FILM NUMBER: 161847348
MAIL ADDRESS:
STREET 1: C/O PUMA BIOTECHNOLOGY, INC.
STREET 2: 10880 WILSHIRE BOULEVARD, SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-22
0
0001401914
Cerulean Pharma Inc.
CERU
0001616230
Senderowicz Adrian
C/O CERULEAN PHARMA INC.
35 GATEHOUSE DRIVE
WALTHAM
MA
02451
0
1
0
0
SVP, Chief Medical Officer
Stock Option (right to buy)
1.14
2016-08-22
4
A
0
100000
0.00
A
2026-08-21
Common Stock
100000
100000
D
This option was granted on August 22, 2016. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of August 22, 2016 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until August 22, 2018.
/s/ Alejandra Carvajal, as attorney-in-fact for Adrian Senderowicz
2016-08-23